ADC Therapeutics SA 10-K filing
Filed 2026-03-10 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0001628280-26-016491
- Form type
- 10-K
- CIK
- 0001771910
- Primary document
- https://www.sec.gov/Archives/edgar/data/1771910/000162828026016491/adc-20251231.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for ADC Therapeutics SA.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $81.4M | - | - |
| Cost Of Revenue | $5.8M | - | - |
| Operating Income | $-121.5M | - | - |
| Net Income | $-142.6M | - | - |
| Eps Basic | -1.12 | - | - |
| Eps Diluted | -1.12 | - | - |
| Cash And Equivalents | $261.3M | - | - |
| Total Assets | $323.1M | - | - |
| Total Liabilities | $509.0M | - | - |
| Shareholders Equity | $-185.8M | - | - |
| Operating Cash Flow | $-141.2M | - | - |
| Capital Expenditures | $264,000 | - | - |